Latest News for: osteoarthritis

Edit

Cytonics Announces that Last Patient Completes Last Visit in First-in-Human Phase 1 Clinical Trial for CYT-108 as a Treatment for Osteoarthritis

PR Newswire 01 Apr 2025
- Phase 1 enrolled 22 patients to examine the safety profile in patients suffering from primary osteoarthritis of the knee - ... If approved, CYT-108 may be the first and only disease-modifying therapy for osteoarthritis.
Edit

Impaired Blairgowrie woman, 77, unable to sleep downstairs after council blocks extension

The Courier 29 Mar 2025
The Perthshire couple applied for a downstairs extension to build a bedroom, accessible bathroom, and storage area so that Gillian could visit her garden ... .
Edit

Health Canada Authorizes 4Moving Biotech to Launch Phase 2a INFLAM MOTION Clinical Trial for Knee Osteoarthritis

Business Wire 27 Mar 2025
LILLE & PARIS, France--(BUSINESS WIRE)--Health Canada Authorizes 4Moving Biotech to Launch Phase 2a INFLAM MOTION Clinical Trial for Knee Osteoarthritis ... .
Edit

Knees Hurt? This Exercise Can Help.

New York Times 26 Mar 2025
Strength training can be one of the best treatments for chronic knee pain. Here’s how to do it safely ... .
Edit

Allegro’s injectable osteoarthritis treatment generates positive safety results in preclinical studies

Nasdaq Globe Newswire 25 Mar 2025
Allegro intends to launch a multi-center pivotal clinical study in osteoarthritis patients in Belgium later this year. .
Edit

Montana State osteoarthritis researcher named fellow of prestigious organization (Montana State University)

Public Technologies 24 Mar 2025
June's research interests include the search for biological markers that may foretell osteoarthritis ... systems biology as they apply to the understanding of osteoarthritis," according to the AIMBE.
Edit

Can-Fite Partner Vetbiolix Accelerate Piclidenoson Development with Advanced Clinical Trial for Canine Osteoarthritis in a ...

Nasdaq Globe Newswire 20 Mar 2025
Can-Fite’s upfront and royalties on sales upon regulatory approval of Piclidenoson for veterinary use, is projected to be $325 million in the aggregate over the next decade assuming a 2029 launch ... .
Edit

Can-Fite Partner Vetbiolix Accelerate Piclidenoson Development with Advanced Clinical Trial for Canine Osteoarthritis in a $3.8 Billion Market (Form 6-K) (Can Fite Biofpharma Ltd)

Public Technologies 20 Mar 2025
Advanced Clinical Trial for Canine Osteoarthritis in a $3.8 Billion Market ... As previously reported, Vetbiolix concluded successfully a clinical study in dogs with osteoarthritis who were treated orally with Piclidenoson for a two months period.
Edit

Vascarta commences a Phase I clinical study of VAS101 in osteoarthritis

Longview News-Journal 18 Mar 2025
... curcumin gel) in osteoarthritis (OA) is underway.
Edit

Elbow osteoarthritis among military Veterans

Rumble 18 Mar 2025
Click the Rumble article link to see the video ....
Edit

Epic Care Offers Low-Dose Radiation Therapy: A Game Changer for Osteoarthritis!

The Mercury News 18 Mar 2025
Low-dose radiation therapy (LD-RT) has been used as a treatment in Europe for decades to reduce pain and inflammation caused by osteoarthritis and other chronic musculoskeletal conditions.
Edit

Enlivex Receives Notice of Allowance for Chinese Patent Application Covering the Use of Allocetra in Patients with Osteoarthritis (Form 6-K) (Enlivex Therapeutics Ltd)

Public Technologies 17 Mar 2025
Enlivex Receives Notice of Allowance for Chinese Patent Application Covering the Use of Allocetra in Patients with Osteoarthritis ... About half of knees with ACL injuries develop osteoarthritis within 5 to 15 years.
×